Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Zrinka Matana Kaštelan is active.

Publication


Featured researches published by Zrinka Matana Kaštelan.


Tumori | 2006

Persistent and progressive st segment elevation caused by myocardial metastasis

Ante Matana; Luka Zaputović; Ksenija Lučin; Zrinka Matana Kaštelan

This is a case of a female patient with collecting duct carcinoma of the right kidney and myocardial metastasis. On electrocardiogram the myocardial metastasis presented with a prolonged and progressive ST elevation and a gradual decrease of the R wave amplitude in leads V3-V6. Echocardiography and autopsy findings confirmed the diagnosis.


Medical Hypotheses | 2014

Can the difference in serum concentration of urea and cystatin C be used in diagnosis and prognosis of heart failure

Ante Matana; Teodora Zaninović Jurjević; Zrinka Matana Kaštelan

Changes in renal function are an important diagnostic and prognostic indicator in patients with heart failure (HF). They are caused by decreased renal perfusion and consequently decreased glomerular filtration rate (GFR), or by the effect of increased neurohormonal activity (sympathetic nervous system [SNS], rennin-angiotensin-aldosterone system [RAAS] and arginine vasopressin [AVP]). However, the increase of serum concentration of urea, creatinine and other metabolites is not specific for HF. Therefore, it is not possible to distinguish HF from renal diseases solely based on the increase of their concentration, since the increase of their concentration caused by the decrease of GFR cannot be differentiated from the increase due to neurohormonal activity. Urea and cystatin C (Cys C) have different mechanisms of renal elimination, so it can be assumed that in HF their concentrations will not be increased proportionally, what can be used for diagnostic and prognostic purposes. After glomerular filtration Cy C undergoes proximal tubular reabsorption and breakdown, without returning to the blood flow. Since it is not secreted, its serum concentration depends only on GFR. In contrast to Cys C, urea is filtered in glomerulus and subsequently reabsorbed in proximal tubules and collecting duct. Reabsorption of urea is modified by effects of SNS, RAAS and AVP. Therefore its serum concentration depends upon GFR and neurohormonal effect on the tubular function. Since the increase of serum concentration of Cys C is caused only by the effect of the decreased renal perfusion on GFR, while the increase of urea is a result from both decreased GFR and tubular effects of increased neurohormonal activity, the paper hypothesis is that in HF the increase of urea will be significantly higher than the increase of serum Cys C, while in the patients with renal diseases their increase would be mostly proportional. It can be assumed that the disproportion between the increase of Cys C and urea would indicate an increased neurohormonal activity in patients with HF and correlate with its activity. If this hypothesis is proved correct, this parameter could be used in HF diagnosis and risk stratification of such patients.


Acta Clinica Belgica | 2018

A simple prognostic model for assessing in-hospital mortality risk in patients with acutely decompensated heart failure

Teodora Zaninović Jurjević; Štefica Dvornik; Slavica Kovačić; Zrinka Matana Kaštelan; Gordana Brumini; Ante Matana; Luka Zaputović

Abstract Background An assessing of the in-hospital mortality risk for an emergency hospitalized patient with acutely decompensated heart failure (ADHF) is challenging task. Simple formula can help. Methods On the base of six indicators identified in derivation group, simple formula for assessing the risk for in-hospital mortality of ADHF patients was derived and later tested in validation group. Results The retrospective analysis of a derivation group (533 survivors, 121 deceased) identified six risk indicators: age, heart rate (HR), systolic blood pressure (SBP) and serum concentrations of urea, sodium (Na) and uric acid (UA). The final formula was created ([age/10]2 × HR/SBP)+(Urea-Na/10)+UA/100 and formula result of 53 was established as cut-off result. In the derivation group, at the cut-off point of 53, area under the ROC curve (AUC) was 0.741 (95% CI 0.701–0.776); with sensitivity 54% and specificity 83%. The discriminative capacity of the formula was significantly higher than each of its components. In the validation group of 591 patients (527 survived, 64 died) AUC was also 0.741 (95% CI 0.706–0.774), sensitivity was 66% and specificity 76%. Positive predictive value (PPV) of the developed formula was modest (34%), but negative predictive value (NPV) was 95%. N-terminal pro-B type natriuretic peptide and troponin I were determined, but not included into formula. Conclusions The developed formula enables simple, rapid and inexpensive risk assessment, but its disadvantage is a low PPV. However, a high NPV permits the identification of patients with a low risk of in-hospital mortality, which could lead to a more rational patient treatment.


Pacing and Clinical Electrophysiology | 2004

Permanent left atrial electromechanical dissociation after conversion of atrial fibrillation in a patient with interatrial block

Ante Matana; Luka Zaputović; Zarko Mavric; Zrinka Matana Kaštelan; Slobodan Romano; Tea Zaninovic-Jurjevic

In a 52‐year‐old woman, pharmacological conversion to sinus rhythm was achieved after 31 days of atrial fibrillation. In spite of permanent sinus rhythm, even 7 months after the conversion, no mechanical left atrial activity was restored, although right atrium showed normal contractility.


Collegium Antropologicum | 2012

The Prevalence of Diabetes Mellitus and Abnormal Lipid Status among Croatian Hospitalized Coronary Heart Disease Patients

Sofija Kukić Brusić; Marin Pušić; Niko Cvjetković; Ružica Karnjuš; Barbara Čandrlić; Melita Kukuljan; Zrinka Matana Kaštelan; Damir Miletić


European Journal of Echocardiography | 2006

The protective effect of mitral stenosis on the embolization of a free-floating left atrial myxoma.

Ante Matana; Luka Zaputović; Ognjen Šimić; Zrinka Matana Kaštelan


Medicina Fluminensis : Medicina Fluminensis | 2017

Kompjutorizirana tomografija i magnetska rezonancija u dijagnostici lezija nadbubrežnih žlijezda

Tiana Grubešić; Zrinka Matana Kaštelan; Berislav Budiselić; Damir Miletić


Medicina Fluminensis : Medicina Fluminensis | 2016

Metastaza hepatocelularnog karcinoma u sakrum – jedina manifestacija bolesti

Zrinka Matana Kaštelan; Tiana Grubešić; Berislav Budiselić; Sandra Milić; Davor Štimac; Damir Miletić


Medicina Fluminensis : Medicina Fluminensis | 2016

Sacral metastasis of hepatocellular carcinoma – the only manifestation of the disease

Zrinka Matana Kaštelan; Tiana Grubešić; Berislav Budiselić; Sandra Milić; Davor Štimac; Damir Miletić


Medicina Fluminensis : Medicina Fluminensis | 2016

Uloga kompjutorizirane tomografi je u dijagnosti ci akutnog abdomena

Tin Nadarević; Tiana Grubešić; Zrinka Matana Kaštelan; Petra Valković Zujić; Marko Zelić; Damir Miletić

Collaboration


Dive into the Zrinka Matana Kaštelan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge